NCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
20 trialsNCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04685928 2025-05-06
SMART
Chinese University of Hong Kong
Phase NA Completed
NCT05384002 2025-04-04
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
Fondazione del Piemonte per l'Oncologia
Completed
NCT02163317 2024-05-10
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT05489341 2023-11-18
Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge
Radboud University Medical Center
Completed
NCT03527199 2023-04-11
Prostate Cancer Patients With Biochemical Recurrence
Saint Louis VA Medical Center
Completed
NCT02681614 2022-06-30
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
Case Comprehensive Cancer Center
Phase NA Completed
NCT03436901 2022-01-03
TENY
Aarhus University Hospital
Phase NA Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02662166 2020-06-17
MIB
Turku University Hospital
Phase NA Completed
NCT02325921 2020-02-24
MRI in Renal Tumors
Radboud University Medical Center
Completed
NCT02488096 2020-01-21
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
Saskatchewan Health Authority - Regina Area
Phase NA Completed
NCT02470910 2019-12-11
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Dana-Farber Cancer Institute
Phase NA Completed
NCT02141490 2019-09-06
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02786459 2019-06-03
ProxiScan
University Health Network, Toronto
Phase NA Completed
NCT01357512 2017-12-02
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
University of Oulu
Phase NA Completed
NCT00252460 2016-03-25
CT/MRI Co-registration Prostate Cancer
University Health Network, Toronto
Completed
NCT02516995 2016-02-10
FIBROP
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed